Management of Group B Streptococcus in Urine
In pregnant women with GBS bacteriuria at any colony count, treat the urinary tract infection according to standard pregnancy UTI protocols AND provide intrapartum antibiotic prophylaxis during labor—no third trimester screening is needed. In non-pregnant patients, do not screen for or treat asymptomatic GBS bacteriuria 1.
Pregnant Patients
Key Management Principles
GBS bacteriuria during pregnancy is an automatic indication for intrapartum antibiotic prophylaxis, regardless of colony count 2. This represents a critical distinction from other populations and supersedes the typical 10^5 CFU/mL threshold used for other bacteria.
Specific Actions Required:
- Treat symptomatic or asymptomatic GBS UTI according to current pregnancy UTI standards when initially detected 2
- Document GBS bacteriuria status prominently in the prenatal record
- Administer intrapartum IV antibiotic prophylaxis when labor begins or membranes rupture 2
- Do NOT perform third trimester vaginal-rectal screening (35-37 weeks)—the patient is presumed GBS-colonized for life of this pregnancy 3
- Do NOT treat with antibiotics before labor to eradicate colonization—this is ineffective and causes harm 2
Intrapartum Antibiotic Regimen:
- First-line: Penicillin G 5 million units IV loading dose, then 2.5-3 million units IV every 4 hours until delivery 2
- Alternative: Ampicillin 2 g IV loading dose, then 1 g IV every 4 hours until delivery 2
- Penicillin allergy without anaphylaxis risk: Cefazolin 2
- High anaphylaxis risk (history of anaphylaxis, angioedema, respiratory distress, or urticaria to penicillin/cephalosporin): Clindamycin or vancomycin based on susceptibility testing 2
Important Caveats:
Exception to prophylaxis: Planned cesarean delivery performed before labor onset with intact membranes does not require GBS prophylaxis, regardless of GBS status 2. However, these women should still undergo routine screening since labor or membrane rupture may occur before the planned cesarean.
The rationale for treating any colony count in pregnancy relates to the high stakes of neonatal early-onset GBS disease and the established link between maternal GBS bacteriuria and heavy colonization 3. Even low colony counts (<10^5 CFU/mL) indicate significant GBS presence warranting intrapartum prophylaxis 3.
Non-Pregnant Patients
Do not screen for or treat asymptomatic GBS bacteriuria in non-pregnant adults 1. This recommendation is based on the 2019 IDSA guidelines for asymptomatic bacteriuria, which found no benefit to treatment in avoiding adverse outcomes while exposing patients to antibiotic-related harms including Clostridioides difficile infection, antimicrobial resistance, and drug adverse effects.
When GBS Bacteriuria May Be Clinically Significant:
While routine screening and treatment are not recommended, GBS can occasionally cause symptomatic UTI in non-pregnant adults, particularly in those with:
- Urinary tract abnormalities (60% of cases) 4
- Chronic renal failure (27% of cases) 4
- Immunocompromised states 4
In these symptomatic cases, treat according to standard UTI protocols with appropriate antibiotics. GBS is typically sensitive to penicillins, cephalosporins, and vancomycin but may be resistant to gentamicin 4.
Critical Distinction:
The fundamental difference between pregnant and non-pregnant management stems from different outcome priorities: in pregnancy, the focus is preventing devastating neonatal sepsis, meningitis, and mortality; in non-pregnant adults, treatment of asymptomatic bacteriuria provides no benefit and causes harm 1.